Drawing for BEXLUTRY

USPTO serial 98531767

BEXLUTRY

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
GREEN, ASHLEY ELIZABETH
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEXLUTRY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie N. Nikitenko

Stephanie N. Nikitenko IpHorgan Ltd195 Arlington Heights Road, Suite #125Buffalo Grove, IL 60089United States

Goods and services

ClassDescriptionStatusFirst use
005Radiopharmaceutical products for the treatment of cancerACTIVEOct 31, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 11, 2026IUAFUSE AMENDMENT FILED—
Nov 11, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 29, 2026EX3GSOU EXTENSION 3 GRANTED—
Apr 29, 2026EXT3SOU EXTENSION 3 FILED—
Apr 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 24, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2025EX2GSOU EXTENSION 2 GRANTED—
Oct 23, 2025EXT2SOU EXTENSION 2 FILED—
Oct 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2025EX1GSOU EXTENSION 1 GRANTED—
May 14, 2025EXT1SOU EXTENSION 1 FILED—
May 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 19, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 8, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 8, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2024DOCKASSIGNED TO EXAMINER—
Jul 15, 2024TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 15, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance